These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29345240)
1. Polymeric bioresorbable coronary scaffolds: the hype is over, but the dream lives on. Pyxaras SA; Wijns W EuroIntervention; 2018 Jan; 13(13):1506-1509. PubMed ID: 29345240 [No Abstract] [Full Text] [Related]
2. The future of bioresorbable vascular scaffolds: niche or workhorse devices? Lahoud R; Ellis S Coron Artery Dis; 2017 Sep; 28(6):449-451. PubMed ID: 28644214 [No Abstract] [Full Text] [Related]
3. Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions. Jabbour RJ; Tanaka A; Capranzano P; Cortese B; Lesiak M; Testa L; Gatto P; Suarez de Lezo J; Mattesini A; Geraci S; Ielasi A; Diletti R; Capodanno D; Buccheri D; Iwanczyk S; Bedogni F; Tchetche D; Di Mario C; Caramanno G; Van Mieghem NM; Tamburino C; Colombo A; Latib A JACC Cardiovasc Interv; 2017 Apr; 10(7):743-745. PubMed ID: 28385415 [No Abstract] [Full Text] [Related]
4. Very Late Restenosis Following Bioresorbable Scaffold Implantation. Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033 [No Abstract] [Full Text] [Related]
5. Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions. Capodanno D; Angiolillo DJ JACC Cardiovasc Interv; 2017 Mar; 10(5):425-437. PubMed ID: 28279311 [TBL] [Abstract][Full Text] [Related]
6. Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial). Jensen LO; Maeng M; Raungaard B; Hansen KN; Kahlert J; Jensen SE; Hansen HS; Lassen JF; Bøtker HE; Christiansen EH EuroIntervention; 2018 Jan; 13(13):1587-1590. PubMed ID: 28870882 [No Abstract] [Full Text] [Related]
7. Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds. Gori T; Schulz E; Münzel T JACC Cardiovasc Interv; 2014 Oct; 7(10):1194-5. PubMed ID: 25240537 [No Abstract] [Full Text] [Related]
8. Very Late Scaffold Thrombosis in Absorb BVS: Association With DAPT Termination? Felix CM; Vlachojannis GJ; IJsselmuiden AJ; Onuma Y; van Geuns RJ JACC Cardiovasc Interv; 2017 Mar; 10(6):625-626. PubMed ID: 28335902 [No Abstract] [Full Text] [Related]
9. The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. Bangalore S; Bezerra HG; Rizik DG; Armstrong EJ; Samuels B; Naidu SS; Grines CL; Foster MT; Choi JW; Bertolet BD; Shah AP; Torguson R; Avula SB; Wang JC; Zidar JP; Maksoud A; Kalyanasundaram A; Yakubov SJ; Chehab BM; Spaedy AJ; Potluri SP; Caputo RP; Kondur A; Merritt RF; Kaki A; Quesada R; Parikh MA; Toma C; Matar F; DeGregorio J; Nicholson W; Batchelor W; Gollapudi R; Korngold E; Sumar R; Chrysant GS; Li J; Gordon JB; Dave RM; Attizzani GF; Stys TP; Gigliotti OS; Murphy BE; Ellis SG; Waksman R JACC Cardiovasc Interv; 2017 Dec; 10(23):2349-2359. PubMed ID: 29216997 [TBL] [Abstract][Full Text] [Related]
11. Coronary Artery Aneurysm With Thrombosis After Implantation of a Bioresorbable Coronary Artery Scaffold. Hemetsberger R; Gürocak O; Soud M; Garcia-Garcia HM; Weber-Albers J; Nef H; Möllmann H JACC Cardiovasc Interv; 2017 Sep; 10(18):e173-e174. PubMed ID: 28935086 [No Abstract] [Full Text] [Related]
12. Bioresorbable Stents: Is This Where We Are Headed? Wayangankar SA; Ellis SG Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497 [TBL] [Abstract][Full Text] [Related]
13. Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution. Tanaka A; Latib A; Jabbour RJ; Mitomo S; Regazzoli D; Leone PP; Chieffo A; Carlino M; Montorfano M; Colombo A JACC Cardiovasc Interv; 2017 Apr; 10(7):745-746. PubMed ID: 28385416 [No Abstract] [Full Text] [Related]
14. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis. Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302 [No Abstract] [Full Text] [Related]
15. Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition. Meincke F; Spangenberg T; Heeger CH; Bergmann MW; Kuck KH; Ghanem A JACC Cardiovasc Interv; 2015 Nov; 8(13):1768-9. PubMed ID: 26476613 [No Abstract] [Full Text] [Related]
16. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months. Kang SH; Kang SJ; Kim WJ JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035 [No Abstract] [Full Text] [Related]
17. Bioresorbable vascular scaffolds: Time to absorb past lessons or fade away? de Pommereau A; de Hemptinne Q; Varenne O; Picard F Arch Cardiovasc Dis; 2018 Apr; 111(4):229-232. PubMed ID: 29678390 [No Abstract] [Full Text] [Related]
18. Is There Light at the End of the Thin-Strut Tunnel?: In Vitro Insights on Strut Thickness Impact on Thrombogenicity in Bioresorbable Stents or Scaffolds. Lu S; Ng J; Ang H; Paradies V; Wong PE; Al-Lamee R; Al-Lamee K; Bullett N; Ahmed N; Joner M; Foin N JACC Cardiovasc Interv; 2018 Apr; 11(7):714-716. PubMed ID: 29622153 [No Abstract] [Full Text] [Related]
20. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis. Lee WC; Fang HY; Fang CY Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437 [No Abstract] [Full Text] [Related] [Next] [New Search]